Syndax Pharmaceuticals, Inc.

SNDX·NasdaqGS·Healthcare
Compare
10.45−3.84 (−26.87%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market10.61+0.16 (+1.53%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close14.29
Open14.55
Day range10.0014.69
52-week range9.9925.59
Off day high−28.86%
Off 52-week high−59.16%
Volume14.90M
Avg. volume (3M)2.21M
Market cap940.80M
EPS (TTM)-2.37
Forward P/E-14.41
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.45
Shares outstanding90.03M
Short interest20.51% of float
Earnings dateNov 2, 2026
Analyst target37.27
Profit margin−87.52%

Against its peers

Compare in full ›
SNDX RCUS AVBP VSTM AGMB RLAY
Market cap 940.80M 2.43B 665.16M 1.20B 337.35M 3.95B
P/E (TTM) — — — — — —
Forward P/E -14.4 -6.2 -3.6 -8.1 -3.4 -11.0
Price/book -54.7 3.8 1.8 17.8 2.7 5.5
Dividend yield — — — — — —
1-year change −28.86% −1.28% −26.64% +24.21% −53.24% +176.11%
Today −26.87% +2.12% +3.61% +0.82% 0.00% +3.38%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All SNDX news ›
Markets Daily·Negative

Synlogic (SYBX) Projected to Post Earnings on Wednesday

Posted by Danessa Lincoln on Nov 4th, 2026 Synlogic (NASDAQ:SYBX – Get Free Report) will likely be issuing its Q3 2026 resultson Wednesday, November 11th. Analysts expect the company to announce earnings of ($5.80) per share for the…

tradingkey.com·Positive

Syndax Q3 Revenue Hits $83.3 Million on Drug Growth

Syndax Pharmaceuticals Inc. (SNDX) reported a sharp increase in third-quarter 2026 revenue as Revuforj prescriptions continued to grow and its share of Niktimvo commercial profit increased. Total revenue reached $83.3 million, up from…

From the 4Search news index, newest first.

In the news

21mentions in 30 days
15with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 21 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance